Search
Oxyphenisatin
go.drugbank.com/drugs/DB04823ApprovedWithdrawnA laxative that undergoes enterohepatic circulation. It may cause jaundice.
Categories: Alimentary Tract and MetabolismBacillus amyloliquefaciens
go.drugbank.com/drugs/DB15667InvestigationalMixtures: Lamwave antimicrobial hand sanitizers gel, Lamwave antimicrobial hand sanitizers gelBrasofensine
go.drugbank.com/drugs/DB04857ExperimentalBrasofensine is an orally administered dopamine reuptake inhibitor being developed for the treatment of Parkinson's Disease. Phase I/II trials for brasofensine have been completed in the U.K. … In November 2001, NeuroSearch confirmed that the drug's development was discontinued in favor of NS 2230.
Talacotuzumab
go.drugbank.com/drugs/DB14796InvestigationalTalacotuzumab is an IgG1 monoclonal antibody directed toward the IL3 receptor α–subunit, also known as CD123.
Categories: Amino Acids, Peptides, and ProteinsNP2
go.drugbank.com/drugs/DB06308InvestigationalNP2 is a replication defective HSV-1 based gene transfer vector engineered to express human preproenkephalin.
Litronesib
go.drugbank.com/drugs/DB11861InvestigationalLitronesib has been used in trials studying the treatment of Solid Tumors, Ovarian Cancer, Gastric Cancer, Prostate Cancer, and Acute Leukaemia, among others.
Preladenant
go.drugbank.com/drugs/DB11864InvestigationalPreladenant has been used in trials studying the treatment of Brain Diseases, Parkinson Disease, Movement Disorders, Antipsychotic Agents, and Parkinsonian Disorders, among others.
RRx-001
go.drugbank.com/drugs/DB12060InvestigationalRRx-001 has been used in trials studying the treatment of Lymphomas, Brain Metastases, Cholangiocarcinoma, Colorectal Neoplasms, and Malignant Solid Tumor, among others.
Synonyms: N-(Bromoacetyl)-3,3-DinitroazetidineOrantinib
go.drugbank.com/drugs/DB12072InvestigationalOrantinib has been used in trials studying the treatment of Lung Cancer, Breast Cancer, Kidney Cancer, Gastric Cancer, and Prostate Cancer, among others.
Devimistat
go.drugbank.com/drugs/DB12109InvestigationalDevimistat (CPI-613) has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Advanced Cancer, and Pancreatic Cancer, among others.